The summary of the text is: The proposition of law aims to improve the financing of research on rare diseases and cancer in children by creating a new funding for supporting innovation therapeutic in certain pathologies pediatriques. The commission has found a point of equilibrium on the rate of the contribution, but it is not favorable to the conditionality of this contribution because it sees a factor of heaviness administrative, nuisible à l'efficacité du dispositif. The government also shares the same opinion and is unfavorable to the amendement.
Voir la source originale